Eli Lilly and (LLY) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- $8.38
- Estimate
- $6.58
- Surprise
- +27.3%
- Revenue (period 2026-06-30)
- $22.97B
- Score at report (before → after)
- 6.4 → 6.6/10
Revenue source: xbrl.
How the report landed
Eli Lilly and (LLY) beat the $6.58 estimate with adjusted EPS of $8.38 — a large 27.3% upside surprise. TrendMatrix's engine moved from Hold (6.4/10) to Buy (Wait) at 6.6/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates LLY Buy (Wait) at 6.4/10.
4 of the last 4 quarters beat the estimate; this quarter's +27.3% surprise compares with a +20.4% four-quarter average. Next scheduled report: 2026-10-29.
What supports the rating
- V7 flight-to-quality bonus: +0.5 (Q=8.3 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Thin upside margin: 4.6%
- Leverage penalty (D/E 1.6): -1.0
- Expensive valuation
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $1142.85
- Entry target
- $1068.55
- Price target
- $1195.95
- Stop
- $1006.15
- Upside to target
- +4.6%
- Reward-to-risk
- 0.8:1
The stock trades at 38.6× trailing but 24.0× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-10-03 — shown for context, not personalized investment advice.
LLY at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Drug Manufacturers - General
- Market cap
- $1018.69B
- P/E (fwd)
- 24.0
- P/E (ttm)
- 38.6
- 52-week range
- $783.85–$1292.65
- Off 52-week high
- 11.6%
- RSI (14)
- 52
- Volume vs avg
- 0.91×
- Score today
- 6.4/10